The Institute for OneWorld Health, the first nonprofit pharmaceutical company in the United States, today announced that CEO Victoria Hale, Ph.D., has been named a Leadership Foundation Fellow for 2003-2004. Hale is one of 14 women selected from a field of more than 50 finalists from all over the world. She is founder and CEO of OneWorld Health, whose experienced team of pharmaceutical scientists uncovers promising drug candidates and advances them through clinical trials and regulatory approval to treat the poorest people in the developing world.
This honor is the third international award in three weeks that recognizes Hale's leadership and vision in establishing OneWorld Health. On Sept. 3 she was named one of five global laureates in health by the Tech Museum of Innovation (San Jose, Calif.). One week prior to that, she was selected as one of 10 outstanding global entrepreneurs by the Schwab Foundation for Social Entrepreneurship in Geneva, Switzerland (http://www.oneworldhealth.org/news/news.html).
The Leadership Foundation is the educational and charitable arm of the International Women's Forum, a global association of about 3,800 top women leaders from 20 countries. The Leadership Foundation Fellows Program is the only leadership training of its kind in the world, designed for women of cultural, professional and geographic diversity. Aimed at high potential women who have the ability to excel at the highest levels of their organizations, the Fellows Program sustains, grooms and promotes up-and-coming women leaders.
Hale's pharmaceutical career spans 15 years, including regulatory and industry experience at the U.S. Food and Drug Administration and biotech pioneer Genentech, Inc. At the FDA, Hale and a team of colleagues led a successful two-year campaign to ensure women and minorities were included in clinical trials, ending an exclusionary practice that persisted inPage: 1 2 Related biology news :1
Contact: Joanne Hasegawa
Institute for OneWorld Health
. Schwab foundation names Victoria Hale a social entrepreneur for 20042
. NIH awards $18.2m to The Burnham Institute to develop Center on Proteolytic Pathways3
. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases4
. The future of HIV therapeutics is brightening, according to Gladstone Institutes Director5
. Institute for OneWorld Health nominated for the 2004 World Technology Awards6
. UNC researchers awarded $8.65 million from National Institute on Aging7
. Institute for OneWorld Health receives Gates Foundation grant8
. Lupus Research Institute awards $3 million in novel research grants to further new science in lupus9
. Virginia Bioinformatics Institute researcher advances fight against sudden oak death disease10
. Institute for OneWorld Health CEO to speak at BIO on leveraging opportunities for global health11
. Institute for OneWorld Health CEO advocates focus first on developing world markets